In their study, younger age, hypertension, prior (non-)sustained VA, decreased LVEF, LV dilatation, late gadolinium enhancement (LGE) and genetic mutations (Phospholamban (PLN), Lamin A/C (LMNA), and Filamin-C (FLNC)) were significant predictors of arrhythmic events. This evidence concerns the gene FLNC and hypertensive disorder.